Navigation Links
Superior in Medical Technology

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... with denosumab treatment was not statistically superior compared to Zometa (adjusted p=0.06) (secondary ... also numerically greater but not statistically superior compared to Zometa (hazard ratio 0.90, 95 percent ... endpoints were to evaluate if denosumab is superior to Zometa with respect to the first on-study SRE, ...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

... primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. Superiority was ... endpoints were to evaluate if denosumab was superior to Zometa with respect to the first on-study SRE, ... have lower prices, established reimbursement, superior performance, are easier to administer, or that ...

Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment

... radiofrequency catheter was statistically superior to laser treatment in providing a fast and ... and quality-of-life parameters were superior in the ClosureFAST group, and minor complications ... as performed with the ClosureFAST catheter, superior to EVL as measured by a comprehensive array of ...

Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

... models. "In all cases, thiarabine demonstrated superior tumor growth inhibition than clofarabine when the ... of these two agents, efficacy was dramatically superior to the use of either agent alone. Tumor ... combinations have significantly superior efficacy to cytarabine/clofarabine combinations ...

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

... for schizophrenia, and Fanapt(TM) was shown to be superior to placebo in controlling symptoms of ... (Geodon(R)), the 24 mg/day Fanapt(TM) dose was superior to placebo in the Positive and Negative Syndrome ... (Risperdal(R)), both doses of Fanapt(TM) were superior to placebo on the Brief Psychiatric Rating Scale ...

Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART

... . Clevudine was superior to Lamivudine in the Patients with ... 48-weeks of dosing with clevudine 30mg showed superior viral suppression to lamivudine 100mg without the ... at Day 15. Twice-daily (BID) administration was superior to once-daily (QD) administration for antiviral ...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

... better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available ... better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about these Takeda companies, visit ...

Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain

... Results Show superior Decrease in Pain Scores Compared to Saline PARSIPPANY, N.J., May 13 ... osteoarthritis (OA) at 26 weeks. The study showed that EUFLEXXA (R) is superior to saline in decreasing pain at 26 weeks in patients with OA of the ...

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting

... in the CAC model for at least 8 hours after dosing and statistically superior to placebo in reducing ocular itching at CAC tests conducted 15 minutes, 8 ... spaced two weeks apart. The results showed Bepreve 1.5% was statistically superior to placebo for at least 8 hours after ophthalmic dosing for reducing ...

MedNet Solutions to Share Industry Expertise at the 13th Annual EDC & Beyond Conference in Orlando, FL

... traditional monitoring inefficiencies can be dramatically reduced through superior data visibility, workflow enhancements and productivity tools. Mr. Friend ... spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please ...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

... In the primary analysis, PEGINTRON maintenance therapy was not superior to observational control in preventing the occurrence of clinical events. ... virologic response (SVR)(3) with 72-week treatment was not statistically superior to the 48-week treatment in slow responders (47.9 percent (35/73) vs. 43.0 ...

Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories

... of acne. In pivotal Phase III clinical trials, Acanya Gel showed superior efficacy to the vehicle gel and either individual active ingredient, while ... product. In pivotal Phase III clinical trials, Acanya Gel showed superior efficacy to the vehicle gel and either individual active ingredient, while ...

Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial

... better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available ... against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive ...

Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone

... dose resveratrol accompanied by an array of other small molecules may be superior to resveratrol alone. According to a mouse study conducted ... Researchers at Appalachian State University found Longevinex(R) had superior antioxidant and anti-inflammatory action among endurance athletes compared ...

Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout

... better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available ... better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about these Takeda companies, visit ...

Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness

... include direct comparisons to existing estrogen therapies, showing VG101's superior efficacy at a cellular level. "Vaginal dryness is a very painful, day to ... given the data we have developed on this drug candidate, VG101 could be a superior treatment for the millions of women who want to improve both their quality ...

Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD

... by next year." The study showed that Clonicel was statistically superior to placebo on the primary endpoint, the ADHD Rating Scale of 18 symptoms. Clonicel was also statistically superior to placebo on several secondary scales completed by clinicians and ...

Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin

... GINGER (a clinical trial) and LACE (real life patient data) confirmed the superior efficacy of LANTUS(R)/APIDRA(R) basal-bolus therapy when compared to ... intensified insulin therapy with LANTUS(R) and APIDRA(R) results in superior glycemic control. The number of patients who reached A1C <7.0% at endpoint ...

Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis

... conducted in mice treated similarly, CEL-2000 was equivalent or possibly superior to Enbrel in slowing disease progression and lessening symptoms. The new ... arthritis damage in humans. CEL-2000 was as good as, and possibly superior to, Enbrel in slowing further disease progression as evaluated by these ...

New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI

... AndroGel was effective in restoring testosterone levels and in some cases, superior to a transdermal testosterone patch. In 2004, an additional follow-up, ... effective in restoring testosterone levels to normal and in some cases, superior to a transdermal testosterone patch. -- AndroGel was effective in ...

Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting

... versus placebo; olanzapine was also demonstrated to be statistically superior to placebo; there was no direct comparison between asenapine and ... and Negative Syndrome Scale (PANSS) total score and was significantly superior to placebo. PANSS total score is a measure of positive symptoms (e.g., ...

Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting

... was well-tolerated, with minimal weight loss. NKTR-102 also exhibited superior pharmacokinetics in a repeated dose study in dogs, with a 6-fold increase ... dosing in dogs" #5742: "NKTR-102, a novel PEGylated-irinotecan, has a superior acute safety, tolerability, and pharmacokinetic profile compared to ...

FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008

... volunteers. ARI-2243 is a highly potent DPP-4 inhibitor, possessing superior preclinical efficacy and a high therapeutic index established in ... efficacy of ARI-2243, the company believes that low doses will produce superior blood glucose lowering compared with other DPP-4 inhibitors. Arisaph ...

Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache

... for pain relief response, all three dose groups were statistically superior (p < 0.05) to placebo during the 4-hour post-treatment time period that ... analysis for pain free response, all three dose groups were statistically superior (p < 0.05) to placebo during the 4-hour post-treatment time period that ...

Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective

... ratio of efficacy to side effects of the VNUS ClosureFAST catheter to be superior to any previous endovenous ablation device," said Dr. Proebstle. "In 223 ... it clear that radiofrequency vein ablation with the ClosureFAST device is superior to laser ablation in terms of patient comfort and satisfaction," said Dr. ...

IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology

... of L-MTP-PE to chemotherapy following surgery resulted in statistically superior Overall Survival (OS) the first stated aim of the study. In the past two ... Survival (EFS) additional analysis. "These findings of statistically superior overall survival in long-term patient follow-up validate the survival ...

IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients

... that typically affects children and young adults, achieved statistically superior Overall Survival (OS) rates. "The statistically significant survival ... Phase 3 clinical trial data was further strengthened by the statistically superior findings in long-term patient follow-up," said Timothy P. Walbert, ...

New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo

... total score. The results showed that CONCERTA(R) achieved a significantly superior reduction in AISRS total score compared to placebo (p=0.012) (mean change ... +/-1.06 for the placebo group. In addition, CONCERTA(R) was significantly superior compared to placebo for the key secondary efficacy variables: change in ...

Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial

... at one year. These MACE results are consistent with the clinically superior 44 percent reduction in MACE observed for XIENCE V at nine months. ... XIENCE V continues to demonstrate longer-term safety and consistently superior efficacy results across the SPIRIT trials with the potential to raise the ...

Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial

... In Difficult-to-Immunize Population, Demonstrates superior Long-Term Seroprotection Compared to Conventional Vaccine ... These data confirm earlier clinical studies showing that HEPLISAV has superior immunogenicity and comparable tolerability to Engerix-B. The overall ...

Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma

... that trial suggested that patients in this group achieved a significantly superior outcome (see table below). "Genasense plus dacarbazine yielded superior results in a large randomized trial," said Dr. Agop Bedikian, Professor of ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our ...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... anabolic treatment for osteoporosis," said C. Richard Lyttle, PhD, President and CEO of Radius. "We are especially encouraged by BA058's superior efficacy in building new bone rapidly, particularly at the femoral neck, since hip fractures are one of the most serious complications of ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... acute symptom control studies and a longer-term maintenance study that compared INVEGA(R) SUSTENNA(TM) to placebo. INVEGA(R) SUSTENNA(TM) was superior to placebo in improving positive and negative syndrome scale (PANSS) total scores in the acute treatment trials and significantly delayed time to ...

Covance Receives Highest Level of Phase I Accreditation

... said Rob Aspbury, M.D., managing director, clinical research services, Covance. "As an industry leader in clinical pharmacology, Covance provides superior experience and expertise in study design and conduct to support today's increasingly complex first-in-human trials." MHRA accreditation was ...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... rate is 54% at a median follow up of 4.5 years (range 2.4 to 7.4) for the 30 surviving patients. Although not a direct comparison, the results are superior to those observed following vaccination with irradiated tumor cells in 48 melanoma patients in a previous trial (64 vs. 31 months, p=.016). Eight ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... Trial (ISAT) - which ultimately was halted due to overwhelming evidence that minimally invasive coiling (an endovascular therapy) was, on average, superior to traditional surgical clipping in the treatment of brain aneurysms - many studies have continued to prove the short- and long-term viability of ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... approximately 90 percent of the rat's 25,000-30,000 estimated genes are analogous to those in humans and mice, and their larger size makes them a superior model for drug-evaluation studies using serial sampling. Generating rats with knockout mutations has been a major challenge, but the new technique ...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

... to either exenatide once weekly or Lantus((R)) (insulin glargine). Patients randomized to exenatide once weekly experienced a statistically superior reduction in A1C, a measure of average blood sugar over three months, of 1.5 percentage points from baseline, compared to a reduction of 1.3 ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... Vice President, Research and Development, HGS. "We are delighted to report that the efficacy of treatment with BENLYSTA plus standard of care was superior in this study to that of placebo plus standard of care, while the safety profile was comparable overall to placebo. BENLYSTA met the primary ...
Other Contents
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
(Date:2/12/2015)... Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62/113114 for DISTRIBUTED METHOD AND SYSTEM ... The patent further establishes NXT-ID,s position in the emerging ... portfolio the ability for multiple devices to collaborate with ...
(Date:2/10/2015)...  Alere Inc. (NYSE: ALR), a global leader ... the quarter ended December 31, 2014. ... Alere said, "We made substantial progress in the ... leader in rapid diagnostics and delivering against our ... in early January enabled us to substantially reduce ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
(Date:2/26/2015)... (PRWEB) February 26, 2015 SpendWell ... celebrated its launch to its first customer today, ... and their covered dependents. , SpendWell delivers ... care services, combining real-time price transparency with e-commerce. ... variety of routine health care services and allows ...
(Date:2/26/2015)... 26, 2015 In a nested-case control study ... world with a relatively low incidence of liver cancer, statin ... according to a new study published February 26 ... , Previous studies have reported this association but most used ... cancer incidence rate, such as Asia. Katherine A. McGlynn, Ph.D., ...
(Date:2/26/2015)... February 26, 2015 The Reproductive Science ... their newly renovated office in Lawrenceville, NJ. ... Center of New Jersey’s physicians, and NJ Top Docs, ... care in the areas of infertility and reproductive medicine. ... excellent success rates and providing current, high quality medical ...
(Date:2/26/2015)... Austin, Texas (PRWEB) February 26, 2015 The ... only enabled local pastor and Central Texas resident John Short ... so much, he has set out to climb Mt. Kilimanjaro, ... to help stop human trafficking. , Starting in his late ... worsened and eventually his hip bones and sockets were bone ...
(Date:2/26/2015)... 2015 Eating disorders are serious, ... adulthood. In response to emerging research regarding eating ... of National Eating Disorders Awareness Week, the Society ... evidence-based recommendations for the medical management of restrictive ... a new approach to assessing the degree of ...
Breaking Medicine News(10 mins):Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3
Other TagsOther Tags